Cat. No.: DAA-001130
Product Information | |
---|---|
Product Name | Human HNF-4-α ELISA Kit |
Species | Human |
Description | Human HNF-4-α ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of HNF-4-α protein in cell culture extracts. It uses our proprietary ELISA technology. Quantitate Human HNF-4-α with 3.3 pg/mL sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
Sample Types | Cell Culture Extracts |
Detection Range | 31 pg/mL - 2000 pg/mL |
Sensitivity | 3.3 pg/mL |
Target Information | |
---|---|
Target Name | HNF4A |
UniProt No. | P41235 |
Gene ID | 3172 |
Target Description | Transcriptionally controlled transcription factor. Binds to DNA sites required for the transcription ofα 1-antitrypsin, apolipoprotein CIII, transthyretin genes and HNF1-α. May be essential for development of the liver, kidney and intestine. |
Alternative Names | FLJ39654; FRTS4; Hepatic nuclear factor 4α; Hepatocyte nuclear factor 4; Hepatocyte nuclear factor 4α; Hepatocyte nuclear factor 4-α; HNF 4; HNF 4α; HNF-4-α; HNF4; HNF4A; HNF4A_HUMAN; HNF4a7; HNF4a8; HNF4a9; Hnf4α; HNF4α10/11/12; MODY; MODY 1; MODY1; NR2A1; NR2A21; Nuclear receptor subfamily 2 group A member 1; OTTHUMP00000031060; OTTHUMP00000031062; TCF; TCF 14; TCF-14; TCF14; Tcf4; Transcription factor 14, hepatic nuclear factor; Transcription factor 14; Transcription factor HNF 4; Transcription factor HNF-4; Transcription factor HNF4 |
Shipping & Storage | |
---|---|
Sipping | Shipping on dry ice. |
Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.